Fischer V - Search Results

1

Absorption, metabolism, and excretion of [14C]vildagliptin, a novel dipeptidyl peptidase 4 inhibitor, in humans.

He H, Tran P, Yin H, Smith H, Batard Y, Wang L, Einolf H, Gu H, Mangold JB, Fischer V, Howard D. He H, et al. Among authors: fischer v. Drug Metab Dispos. 2009 Mar;37(3):536-44. doi: 10.1124/dmd.108.023010. Epub 2008 Dec 15. Drug Metab Dispos. 2009. PMID: 19074975

2

Disposition of vildagliptin, a novel dipeptidyl peptidase 4 inhibitor, in rats and dogs.

He H, Tran P, Yin H, Smith H, Flood D, Kramp R, Filipeck R, Fischer V, Howard D. He H, et al. Among authors: fischer v. Drug Metab Dispos. 2009 Mar;37(3):545-54. doi: 10.1124/dmd.108.023002. Epub 2008 Dec 15. Drug Metab Dispos. 2009. PMID: 19074976

3

Methanol solvent may cause increased apparent metabolic instability in in vitro assays.

Yin H, Tran P, Greenberg GE, Fischer V. Yin H, et al. Among authors: fischer v. Drug Metab Dispos. 2001 Feb;29(2):185-93. Drug Metab Dispos. 2001. PMID: 11159810

4

Efflux transporters and their clinical relevance.

Fischer V, Einolf HJ, Cohen D. Fischer V, et al. Mini Rev Med Chem. 2005 Feb;5(2):183-95. doi: 10.2174/1389557053402756. Mini Rev Med Chem. 2005. PMID: 15720288 Review.

5

Metabolism and Disposition of Hepatitis C Polymerase Inhibitor Dasabuvir in Humans.

Shen J, Serby M, Reed A, Lee AJ, Menon R, Zhang X, Marsh K, Wan X, Kavetskaia O, Fischer V. Shen J, et al. Among authors: fischer v. Drug Metab Dispos. 2016 Aug;44(8):1139-47. doi: 10.1124/dmd.115.067512. Epub 2016 May 13. Drug Metab Dispos. 2016. PMID: 27179126

6

Metabolism and Disposition of Pan-Genotypic Inhibitor of Hepatitis C Virus NS5A Ombitasvir in Humans.

Shen J, Serby M, Surber B, Lee AJ, Ma J, Badri P, Menon R, Kavetskaia O, de Morais SM, Sydor J, Fischer V. Shen J, et al. Among authors: fischer v. Drug Metab Dispos. 2016 Aug;44(8):1148-57. doi: 10.1124/dmd.115.067496. Epub 2016 May 13. Drug Metab Dispos. 2016. PMID: 27179128

7

Metabolism and Disposition of the Hepatitis C Protease Inhibitor Paritaprevir in Humans.

Shen J, Serby M, Reed A, Lee AJ, Zhang X, Marsh K, Khatri A, Menon R, Kavetskaia O, Fischer V. Shen J, et al. Among authors: fischer v. Drug Metab Dispos. 2016 Aug;44(8):1164-73. doi: 10.1124/dmd.115.067488. Epub 2016 May 13. Drug Metab Dispos. 2016. PMID: 27179127

8

Multiple cytochrome P-450s involved in the metabolism of terbinafine suggest a limited potential for drug-drug interactions.

Vickers AE, Sinclair JR, Zollinger M, Heitz F, Glänzel U, Johanson L, Fischer V. Vickers AE, et al. Among authors: fischer v. Drug Metab Dispos. 1999 Sep;27(9):1029-38. Drug Metab Dispos. 1999. PMID: 10460803

9

In vitro metabolism of tegaserod in human liver and intestine: assessment of drug interactions.

Vickers AE, Zollinger M, Dannecker R, Tynes R, Heitz F, Fischer V. Vickers AE, et al. Among authors: fischer v. Drug Metab Dispos. 2001 Oct;29(10):1269-76. Drug Metab Dispos. 2001. PMID: 11560869

10

The conduct of in vitro and in vivo drug-drug interaction studies: a Pharmaceutical Research and Manufacturers of America (PhRMA) perspective.

Bjornsson TD, Callaghan JT, Einolf HJ, Fischer V, Gan L, Grimm S, Kao J, King SP, Miwa G, Ni L, Kumar G, McLeod J, Obach RS, Roberts S, Roe A, Shah A, Snikeris F, Sullivan JT, Tweedie D, Vega JM, Walsh J, Wrighton SA; Pharmaceutical Research and Manufacturers of America (PhRMA) Drug Metabolism/Clinical Pharmacology Technical Working Group; FDA Center for Drug Evaluation and Research (CDER). Bjornsson TD, et al. Among authors: fischer v. Drug Metab Dispos. 2003 Jul;31(7):815-32. doi: 10.1124/dmd.31.7.815. Drug Metab Dispos. 2003. PMID: 12814957

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

405 results

Search Page

Filters